openPR Logo
Press release

RNA Sequencing Market - With Future Growth By Top Players like Affymetrix Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd

10-10-2018 01:34 PM CET | Health & Medicine

Press release from: Allied Market Research

RNA Sequencing Market

RNA Sequencing Market

The newest research report global RNA Sequencing Market illustrates pin point sharp market insights includes detailed RNA Sequencing industry aspects forecast over a period. It conducts a fervent study of business positions to offer in detail knowledge of RNA Sequencing business habits of past, present, and future.

RNA sequencing or whole transcriptome shotgun sequencing is a process to identify the presence and quantity of RNA present in a biological sample. It enables to analyze the constantly changing cellular transcriptome; identifies gene fusion, post transcriptional modifications, & splicing; and recognizes the exon/intron boundary of the eukaryotic genes.

Get Sample Copy of this Report: https://www.alliedmarketresearch.com/request-toc-and-sample/2980

The market is dominated by players such as

• Affymetrix Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• GE Healthcare
• Illumina Inc.
• Qiagen N.V.
• F. Hoffmann-La Roche Ltd.
• Sigma Aldrich
• Fluidigm Corporation

Advancements of in sequencing technology, increase in acceptance of NGS technology, and growth in number of partnerships & collaborations drive the growth of the global RNA sequencing market. However, dearth of skilled professionals and problems associated with storage of sequencing data restrain the market growth. Government initiatives in population sequencing and emerging markets such as China & India offer significant growth opportunities for the market growth.

Make Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2980

Key Benefits

• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of all geographical regions is provided, which helps to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which help to understand competitive outlook of the global market.
• The report offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Exhaustive analysis of the RNA sequencing market by type helps to understand the types of sequencing technologies that are currently being used along with the variants that are expected to gain prominence in the future.

Access the latest trends and insights: https://www.alliedmarketresearch.com/rna-sequencing-market

About Us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RNA Sequencing Market - With Future Growth By Top Players like Affymetrix Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd here

News-ID: 1293744 • Views:

More Releases from Allied Market Research

Thermoplastic Composites Market Business Opportunities, Challenges, Drivers and Restraint Research Report by 2027
Thermoplastic Composites Market Business Opportunities, Challenges, Drivers and …
The global thermoplastic Composites market is presently driven by the automotive, construction and aerospace industries. In the aerospace & defense industry, the use of thermoplastic composites is primarily intended to minimize the total weight and corrosion in the aircraft structure. In addition, maintenance costs for aircraft produced using composites have significantly decreased compared with maintenance costs for aircraft produced using conventional materials. Thermoplastic composites having various properties including insubstantial weight,
Glass Fiber Reinforced Plastics (GFRP) Composites Market to Reach $37.2 Billion …
Allied Market Research published a report, titled, "Glass Fiber Reinforced Plastic (GFRP) Composites Market by Resin Type (Polyester Resin, Vinyl Ester Resin, Epoxy Resin, Polyurethane Resin, and Others), Process (Manual Process, Continuous Process, Compression Molding, and Injection Molding), and End-Use Industry (Aerospace and Defense, Construction, Wind Energy, Automotive, Electrical and Electronics, and Others): Global Opportunity Analysis and Industry Forecast, 2022-2032". According to the report, the global glass fiber reinforced plastic
India Bitumen Market Statistics, Size Will Hit $6.8 Billion By 2032 | Growth With Recent Trends & Demand
India Bitumen Market Statistics, Size Will Hit $6.8 Billion By 2032 | Growth Wit …
Bitumen is a mixture of viscous, highly sticky, and black organic liquids, which is soluble in carbon disulfide and primarily consists of condensed polycyclic aromatic hydrocarbons. It is a crucial component of asphalt, which is used to build roads, streets, and other parts of infrastructure. One of the primary applications of bitumen is in road construction. It is used as a binder in asphalt concrete, which is a mixture of
Mining Metal Market Size to Worth $1.6 Trillion by 2032 | Major Companies, Strategies and New Trends
Mining Metal Market Size to Worth $1.6 Trillion by 2032 | Major Companies, Strat …
Allied Market Research recently unveiled a report titled "Mining Metal Market," forecasting trends from 2023 to 2032. This market, categorized by type and end-use industry, is set to expand from $1.0 trillion in 2022 to $1.6 trillion by 2032, with a notable CAGR of 5.1% during 2023-2032. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 : https://www.alliedmarketresearch.com/request-sample/504 Prime Determinants of Growth: Several factors fuel the growth of the global mining metal market, including the shift

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and